135 related articles for article (PubMed ID: 9041173)
1. The localization of the HRX/ALL1 protein to specific nuclear subdomains is altered by fusion with its eps15 translocation partner.
Rogaia D; Grignani F; Carbone R; Riganelli D; LoCoco F; Nakamura T; Croce CM; Di Fiore PP; Pelicci PG
Cancer Res; 1997 Mar; 57(5):799-802. PubMed ID: 9041173
[TBL] [Abstract][Full Text] [Related]
2. The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures.
Butler LH; Slany R; Cui X; Cleary ML; Mason DY
Blood; 1997 May; 89(9):3361-70. PubMed ID: 9129043
[TBL] [Abstract][Full Text] [Related]
3. The FEL (AF-4) protein donates transcriptional activation sequences to Hrx-Fel fusion proteins in leukemias containing T(4;11)(Q21;Q23) chromosomal translocations.
Morrissey JJ; Raney S; Cleary ML
Leuk Res; 1997 Oct; 21(10):911-7. PubMed ID: 9403001
[TBL] [Abstract][Full Text] [Related]
4. ALL1 gene alterations in acute leukemia: biological and clinical aspects.
Cimino G; Rapanotti MC; Sprovieri T; Elia L
Haematologica; 1998 Apr; 83(4):350-7. PubMed ID: 9592986
[TBL] [Abstract][Full Text] [Related]
5. A novel gene, AF-1p, fused to HRX in t(1;11)(p32;q23), is not related to AF-4, AF-9 nor ENL.
Bernard OA; Mauchauffe M; Mecucci C; Van den Berghe H; Berger R
Oncogene; 1994 Apr; 9(4):1039-45. PubMed ID: 8134107
[TBL] [Abstract][Full Text] [Related]
6. Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11) (q27;q23) leukemia localize in the nucleus.
Joh T; Yamamoto K; Kagami Y; Kakuda H; Sato T; Yamamoto T; Takahashi T; Ueda R; Kaibuchi K; Seto M
Oncogene; 1997 Oct; 15(14):1681-7. PubMed ID: 9349501
[TBL] [Abstract][Full Text] [Related]
7. ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells.
Rubnitz JE; Morrissey J; Savage PA; Cleary ML
Blood; 1994 Sep; 84(6):1747-52. PubMed ID: 8080983
[TBL] [Abstract][Full Text] [Related]
8. A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias.
Morrissey J; Tkachuk DC; Milatovich A; Francke U; Link M; Cleary ML
Blood; 1993 Mar; 81(5):1124-31. PubMed ID: 8443374
[TBL] [Abstract][Full Text] [Related]
9. The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX.
Slany RK; Lavau C; Cleary ML
Mol Cell Biol; 1998 Jan; 18(1):122-9. PubMed ID: 9418860
[TBL] [Abstract][Full Text] [Related]
10. Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia.
Prasad R; Yano T; Sorio C; Nakamura T; Rallapalli R; Gu Y; Leshkowitz D; Croce CM; Canaani E
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12160-4. PubMed ID: 8618864
[TBL] [Abstract][Full Text] [Related]
11. HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities.
Hunger SP; Tkachuk DC; Amylon MD; Link MP; Carroll AJ; Welborn JL; Willman CL; Cleary ML
Blood; 1993 Jun; 81(12):3197-203. PubMed ID: 8389614
[TBL] [Abstract][Full Text] [Related]
12. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.
Lavau C; Szilvassy SJ; Slany R; Cleary ML
EMBO J; 1997 Jul; 16(14):4226-37. PubMed ID: 9250666
[TBL] [Abstract][Full Text] [Related]
13. Rearrangements involving chromosome band 11Q23 in acute leukaemia.
Rowley JD
Semin Cancer Biol; 1993 Dec; 4(6):377-85. PubMed ID: 8142623
[TBL] [Abstract][Full Text] [Related]
14. Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias.
Cimino G; Rapanotti MC; Biondi A; Elia L; Lo Coco F; Price C; Rossi V; Rivolta A; Canaani E; Croce CM; Mandelli F; Greaves M
Cancer Res; 1997 Jul; 57(14):2879-83. PubMed ID: 9230194
[TBL] [Abstract][Full Text] [Related]
15. HRX leukemic fusion proteins form a heterocomplex with the leukemia-associated protein SET and protein phosphatase 2A.
Adler HT; Nallaseth FS; Walter G; Tkachuk DC
J Biol Chem; 1997 Nov; 272(45):28407-14. PubMed ID: 9353299
[TBL] [Abstract][Full Text] [Related]
16. Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias.
So CW; Lin M; Ayton PM; Chen EH; Cleary ML
Cancer Cell; 2003 Aug; 4(2):99-110. PubMed ID: 12957285
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of the ARP1 gene, a target for the human acute leukemia ALL1 gene.
Arakawa H; Nakamura T; Zhadanov AB; Fidanza V; Yano T; Bullrich F; Shimizu M; Blechman J; Mazo A; Canaani E; Croce CM
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4573-8. PubMed ID: 9539779
[TBL] [Abstract][Full Text] [Related]
18. ENL, the MLL fusion partner in t(11;19), binds to the c-Abl interactor protein 1 (ABI1) that is fused to MLL in t(10;11)+.
García-Cuéllar MP; Schreiner SA; Birke M; Hamacher M; Fey GH; Slany RK
Oncogene; 2000 Mar; 19(14):1744-51. PubMed ID: 10777208
[TBL] [Abstract][Full Text] [Related]
19. ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias.
Nakanishi H; Nakamura T; Canaani E; Croce CM
Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14442-7. PubMed ID: 17726105
[TBL] [Abstract][Full Text] [Related]
20. Interstitial insertion of AF10 into the ALL1 gene in a case of infant acute lymphoblastic leukemia.
Angioni A; La Starza R; Mecucci C; Sprovieri T; Matteucci C; De Rossi G; Balloni P; Cimino G
Cancer Genet Cytogenet; 1998 Dec; 107(2):107-10. PubMed ID: 9844603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
